Inventor · disambiguated record
Jacqueline Bussolari
Also filed as: BUSSOLARI JACQUELINE · BUSSOLARI JACQUELINE C · BUSSOLARI JACQUELINE CIRILLO
12 granted patents·6 pending applications·348 citations·filing 2000–2024
89Inventor score
Files withGERON CORP4JANSSEN PHARMACEUTICA NV4ORTHO MCNEIL PHARM INC4BUSSOLARI JACQUELINE C2CONNOLLY PETER J1
Top patents by PatentIndex Score
18 records- 0198US6750369B2Substituted amino acids as erythropoietin mimeticsORTHO MCNEIL PHARM INC·Filed 2001·Granted Jun 15, 2004·155 cites·17 claims
- 0298US6310078B1Substituted amino acids as erythropoietin mimeticsORTHO MCNEIL PHARM INC·Filed 2000·Granted Oct 30, 2001·179 cites·4 claims
- 0386US11707463B2FGFR2 inhibitors for the treatment of cholangiocarcinomaJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Jul 25, 2023·2 cites·20 claims
- 0482US12350266B2FGFR2 inhibitors for the treatment of cholangiocarcinomaJANSSEN PHARMACEUTICA NV·Filed 2023·Granted Jul 8, 2025·0 cites·20 claims
- 0579US2025170160A1Methods of Treating Myelodysplastic SyndromeGERON CORP·Filed 2024·Application pending·0 cites
- 0678US6838442B2Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulatorsORTHO MCNEIL PHARM INC·Filed 2002·Granted Jan 4, 2005·12 cites·33 claims
- 0768US12201645B2Methods of treating myelodysplastic syndromeGERON CORP·Filed 2019·Granted Jan 21, 2025·0 cites·46 claims
- 0864US12133851B2Treatment of cholangiocarcinomaJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Nov 5, 2024·0 cites·22 claims
- 0959US2023012167A1Inhibitors of bruton's tyrosine kinase and methods of their useJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 1058US7384979B2Substituted amino acids as erythropoietin mimeticsORTHO MCNEIL PHARM INC·Filed 2006·Granted Jun 10, 2008·0 cites·16 claims
- 1154US8278268B2Combination therapy comprising glucose reabsorption inhibitors and PPAR modulatorsBUSSOLARI JACQUELINE C·Filed 2007·Granted Oct 2, 2012·0 cites·29 claims
- 1253US2020063214A1Methods of identifying patients likely to benefit from treatment with a telomerase inhibitorGERON CORP·Filed 2019·Application pending·0 cites
- 1352US8183213B2Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulatorsBUSSOLARI JACQUELINE C·Filed 2007·Granted May 22, 2012·0 cites·5 claims
- 1450US12171778B2Methods of treating myelodysplastic syndromeGERON CORP·Filed 2018·Granted Dec 24, 2024·0 cites·39 claims
- 1550US7153869B2Substituted amino acids as erythropoietin mimeticsCONNOLLY PETER J·Filed 2004·Granted Dec 26, 2006·0 cites·205 claims
- 1649US2003199557A1Combination therapy comprising glucose reabsorption inhibitors and PPAR modulatorsFiled 2003·Application pending·0 cites
- 1747US2003195235A1Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulatorsFiled 2003·Application pending·0 cites
- 1845US2003045553A1Combination therapy comprising glucose reabsorption inhibitors and PPAR modulatorsFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jacqueline Bussolari files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →